Abstract
Disorders of the cell cycle regulatory machinery play a key role in the pathogenesis of cancer. The gene encoding the cyclin D1 protein, a regulator of the progression from the G1- to S-phase, is often found disrupted in the cancer cell genome by the processes of chromosome translocation or gene amplification. Regardless of the mechanism, the end result of these genetic alterations is overexpression of the cyclin D1 mRNA and the protein it encodes. Among the tumors in which cyclin D1 overexpression has been observed are carcinomas of the breast (1,2), colon (3), larynx and esophagus (4,5), lung (6), bladder (7), and ovary (8,9), multiple myeloma (10), and parathyroid adenoma (11). However, the detection of overexpression or the specific chromosome translocation responsible for it has found clinical utility primarily in the diagnosis of mantle cell lymphoma, a small lymphocytic lymphoma composed of CD5-positive, CD10-negative B-lymphocytes that can be mistaken histologically for other types of B-cell non-Hodgkin’s lymphoma (12–14). The distinction is important because mantle cell lymphomas have a less favorable prognosis and require more aggressive therapy than other, microscopically similar lymphomas (15). Genetically, nearly all mantle cell lymphomas have a characteristic translocation, t(11;14) (q13;q32). The translocation breakpoints on chromosome 11q13 invariably lie near the Cyclin D1 gene at that locus, with about one-third lying within the short segment of DNA designated as the major cluster region.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bartkova, J., Lukas, J., Strauss, M., et al. (1994) Cell cycle-related variation and tissue-restricted expression of human Cyclin D1 protein. J. Pathol. 172(3), 237–245.
Vos, C. B., Ter Haar, N. T., Peterse, J. L., et al. (1999) Cyclin D1 gene amplification and overexpression are present in ductal carcinoma in situ of the breast. J. Pathol. 187(3), 279–284.
Bartkova, J., Lukas, J., Strauss, M., et al. (1994) The prad-1/Cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas. Int. J. Cancer 58(4), 568–573.
Jares, P., Fernandez, P. L., Campo, E., et al. (1994) Prad-1/Cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res. 54(17), 4813–4817.
Shinozaki, H., Ozawa, S., Ando, N., et al. (1996) Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information. Clin. Cancer Res. 2(7), 1155–1161.
Reissmann, P. T., Koga, H., Figlin, R. A., et al. (1999) Amplification and overexpression of the Cyclin D1 and epidermal growth factor receptor genes in non-small-cell lung cancer. Lung cancer study group. J. Cancer Res. Clin. Oncol. 125(2), 61–70.
Tut, V. M., Braithwaite, K. L., Angus, B., et al. (2001) Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, prb and ki67. Br. J. Cancer 84(2), 270–275.
Zukerberg, L. R., Yang, W. I., Gadd, M., et al. (1995) Cyclin D1 (prad1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the Cyclin D1 oncogene. Mod. Pathol. 8(5), 560–567.
Barbieri, F., Cagnoli, M., Ragni, N., et al. (1997) Expression of Cyclin D1 correlates with malignancy in human ovarian tumours. Br. J. Cancer 75(9), 1263–1268.
Chesi, M., Bergsagel, P. L., Brents, L. A., et al. (1996) Dysregulation of Cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines. [see comments]. Blood 88(2), 674–681.
Motokura, T. and Arnold, A. (1993) Cyclin D and oncogenesis. Curr. Opin. Genet. Dev. 3(1), 5–10.
Campo, E., Raffeld, M., and Jaffe, E. S. (1999) Mantle-cell lymphoma. Semin. Hematol. 36(2), 115–127.
Garcia-Conde, J. and Cabanillas, F. (1996) Mantle cell lymphoma: a lymphoproliferative disorder associated with aberrant function of the cell cycle. Leukemia 10(Suppl 2), s78–s83.
Kurtin, P. J. (1998) Mantle cell lymphoma. Adv. Anat. Pathol. 5(6), 376–398.
Pittaluga, S., Wlodarska, I., Stul, M. S., et al. (1995) Mantle cell lymphoma: a clinicopathological study of 55 cases. Histopathology 26(1), 17–24.
Avet-Loiseau, H., Garand, R., Gaillard, F., et al. (1998) Detection of t(11;14) using interphase molecular cytogenetics in mantle cell lymphoma and atypical chronic lymphocytic leukemia. Genes Chromosomes Cancer 23(2), 175–182.
Remstein, E. D., Kurtin, P. J., Buno, I., et al. (2000) Diagnostic utility of fluorescence in situ hybridization in mantle-cell lymphoma. Br. J. Haematol. 110(4), 856–862.
Coignet, L. J., Schuuring, E., Kibbelaar, R. E., et al. (1996) Detection of 11q13 rearrangements in hematologic neoplasias by double-color fluorescence in situ hybridization. Blood 87(4), 1512–1519.
Li, J. Y., Gaillard, F., Moreau, A., et al. (1999) Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization. Am. J. Pathol. 154(5), 1449–1452.
Williams, M. E., Swerdlow, S. H., Rosenberg, C. L., et al. (1993) Chromosome 11 translocation breakpoints at the prad1/Cyclin D1 gene locus in centrocytic lymphoma. Leukemia 7(2), 241–245.
Rimokh, R., Berger, F., Delsol, G., et al. (1994) Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas. Blood 83(7), 1871–1875.
Luthra, R., Hai, S., and Pugh, W. C. (1995) Polymerase chain reaction detection of the t(11;14) translocation involving the bcl-1 major translocation cluster in mantle cell lymphoma. Diagn. Mol. Pathol. 4(1), 4–7.
Pinyol, M., Campo, E., Nadal, A., et al. (1996) Detection of the bcl-1 rearrangement at the major translocation cluster in frozen and paraffin-embedded tissues of mantle cell lymphomas by polymerase chain reaction. Am. J. Clin. Pathol. 105(5), 532–547.
Bergsagel, P. L., Nardini, E., Brents, L., et al. (1997) IgH translocations in multiple myeloma: a nearly universal event that rarely involves c-myc. Curr. Topics Microbiol. Immunol. 224, 283–287.
Bosch, F., Jares, P., Campo, E., et al. (1994) Prad-1/Cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood 84(8), 2726–2732.
de Boer, C. J., Schuuring, E., Dreef, E., et al. (1995) Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma. Blood 86(7), 2715–2723.
Zukerberg, L. R., Yang, W. I., Arnold, A., et al. (1995) Cyclin D1 expression in non-Hodgkin’s lymphomas. Detection by immunohistochemistry. Am. J. Clin. Pathol. 103(6), 756–760.
Aguilera, N. S., Bijwaard, K. E., Duncan, B., et al. (1998) Differential expression of Cyclin D1 in mantle cell lymphoma and other non-Hodgkin’s lymphomas. Am. J. Pathol. 153(6), 1969–1976.
Bijwaard, K. E., Aguilera, N. S., Monczak, Y., et al. (2001) Quantitative real-time reverse transcription-PCR assay for Cyclin D1 expression: utility in the diagnosis of mantle cell lymphoma. Clin. Chem. 47(2), 195–201.
Alkan, S., Schnitzer, B., Thompson, J. L., et al. (1995) Cyclin D1 protein expression in mantle cell lymphoma. Ann. Oncol. 6(6), 567–570.
Banno, S., Yoshikawa, K., Nakamura, S., et al. (1994) Monoclonal antibody against prad1/Cyclin D1 stains nuclei of tumor cells with translocation or amplification at bcl-1 locus. Jpn. J. Cancer Res. 85(9), 918–926.
Vasef, M. A., Medeiros, L. J., Koo, C., et al. (1997) Cyclin d1 immunohistochemical staining is useful in distinguishing mantle cell lymphoma from other low-grade B-cell neoplasms in bone marrow. Am. J. Clin. Pathol. 108(3), 302–307.
de Boer, C. J., van Krieken, J. H., Kluin-Nelemans, H. C., et al. (1995) Cyclin d1 messenger rna overexpression as a marker for mantle cell lymphoma. Oncogene 10(9), 1833–1840.
Medeiros, L. J., Hai, S., Thomazy, V. A., et al. (2002) Real-time RT-PCR assay for quantifying Cyclin D1 MRNA in B-cell non-Hodgkin’s lymphomas. Mod. Pathol. 15(5), 556–564.
Chan, J. K., Miller, K. D., Munson, P., et al. (1999) Immunostaining for Cyclin D1 and the diagnosis of mantle cell lymphoma: is there a reliable method? Histopathology 34(3), 266–270.
Applied Biosystems. (1997) User Bulletin #2: Relative Quantitation of Gene Expression. ABI prism 7700 sequence detection system, PE Applied Biosystems, Foster City, CA.
Krafft, A. E., Duncan, B. W., Bijwaard, K. E., et al. (1997) Optimization of the isolation and amplification of RNA from formalin-fixed, paraffin-embedded tissue: The Armed Forces Institute of Pathology experience and literature review. Mol. Diagn. 2(3), 217–230.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Bijwaard, K.E., Lichy, J.H. (2004). Determination of Cyclin D1 Expression by Quantitative Real-Time, Reverse-Transcriptase Polymerase Chain Reaction. In: Roulston, J.E., Bartlett, J.M.S. (eds) Molecular Diagnosis of Cancer. Methods in Molecular Medicine, vol 97. Humana Press. https://doi.org/10.1385/1-59259-760-2:277
Download citation
DOI: https://doi.org/10.1385/1-59259-760-2:277
Publisher Name: Humana Press
Print ISBN: 978-1-58829-160-8
Online ISBN: 978-1-59259-760-4
eBook Packages: Springer Protocols